Revised: 7 November 2019

Information for Healthcare Professionals

This section provides information useful to healthcare professionals.

Healthcare Professional Information

Safety Communications

Unapproved Medicines

Adverse Reaction Reporting

Subscribe

Medsafe Advice

Date Type Title
6/12/2019PublicationsPrescriber Update Volume 40 Number 4 dated December 2019
4/12/2019Media ReleaseMedicines Classification Committee releases latest meeting minutes
4/12/2019CommitteesMinutes of the 63rd meeting of the Medicines Classification Committee held in Wellington on 10 October 2019
4/12/2019CommitteesMedicines Classification Committee - Dates and Deadlines
25/11/2019Media ReleaseTaking multiple medicines? Support the health care system by reporting suspected side effects this #MedSafetyWeek
21/11/2019CommitteesAgenda for the 180th Medicines Adverse Reactions Committee meeting - 5 December 2019
20/11/2019Alert CommunicationConsent to distribute Cafergot tablets (ergotamine tartrate 1 mg + caffeine 100 mg) will be prohibited under Section 36 of the Medicines Act 1981 on 1 May 2020
14/11/2019Monitoring CommunicationM² Logo Possible risk of vasculitis with dabigatran (Pradaxa)
12/11/2019Monitoring CommunicationSuspected adverse reaction reports to lamotrigine after changing brands
12/11/2019Monitoring CommunicationUpdate 7 November 2019 - Breast Implants and anaplastic large cell lymphoma
7/11/2019Monitoring CommunicationEveret (levetiracetam) - supply and potential seizure control issues for patients
6/11/2019Alert CommunicationConsumer level recall of one lot of Avonex Pen 30mcg in 0.5mL, Lot 1422362
4/11/2019ConsultationConsultation on proposed changes to current warning and advisory statements for paracetamol
25/10/2019CommitteesMinutes of the 179th Medicines Adverse Reactions Committee Meeting
21/10/2019Alert CommunicationMedicines containing ranitidine and a potential impurity, N-nitrosodimethylamine (NDMA)
21/10/2019Monitoring CommunicationLosartan approved medicines supplied in New Zealand not affected by recalls overseas
21/10/2019Monitoring CommunicationReview of chemically synthesised active pharmaceutical ingredients for presence of nitrosamine impurity
11/10/2019NoticesMedsafe Office Closure Christmas/New Year 2019/2020
11/10/2019Alert CommunicationSurgical Mesh Implants - Adverse Event Reporting and Monitoring - Link to the latests October 2019 report

If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@health.govt.nz.

Show menus
0 1 2 4 5 6 7 9 [ /